AU2003209669A1 - Amorphous form of losartan potassium - Google Patents
Amorphous form of losartan potassiumInfo
- Publication number
- AU2003209669A1 AU2003209669A1 AU2003209669A AU2003209669A AU2003209669A1 AU 2003209669 A1 AU2003209669 A1 AU 2003209669A1 AU 2003209669 A AU2003209669 A AU 2003209669A AU 2003209669 A AU2003209669 A AU 2003209669A AU 2003209669 A1 AU2003209669 A1 AU 2003209669A1
- Authority
- AU
- Australia
- Prior art keywords
- amorphous form
- losartan potassium
- losartan
- potassium
- amorphous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002083 C09CA01 - Losartan Substances 0.000 title 1
- 229960000519 losartan potassium Drugs 0.000 title 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000037 WO2004076443A1 (en) | 2003-02-25 | 2003-02-25 | Amorphous form of losartan potassium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003209669A1 true AU2003209669A1 (en) | 2004-09-17 |
Family
ID=32922922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003209669A Abandoned AU2003209669A1 (en) | 2003-02-25 | 2003-02-25 | Amorphous form of losartan potassium |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003209669A1 (en) |
| WO (1) | WO2004076443A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076097A2 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
| WO2009004374A1 (en) | 2007-06-29 | 2009-01-08 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
| NZ600010A (en) | 2007-10-24 | 2013-11-29 | Generics Uk Ltd | Novel crystalline forms of bosentan, processes for their preparation and uses thereof |
| NZ587793A (en) | 2008-02-08 | 2012-06-29 | Generics Uk Ltd | Process for preparing bosentan |
| US8975402B2 (en) | 2008-11-03 | 2015-03-10 | Generics [Uk] Limited | HPLC method for the analysis of bosetan and related substances and use of these substances as reference standards and markers |
| CN109320501B (en) * | 2013-11-01 | 2021-06-01 | 深圳信立泰药业股份有限公司 | Allisartan isoproxil amorphous form, preparation method thereof and pharmaceutical composition containing amorphous form |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5140037A (en) * | 1990-03-20 | 1992-08-18 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| WO2003048135A1 (en) * | 2001-11-14 | 2003-06-12 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of losartan potassium and process for their preparation |
-
2003
- 2003-02-25 AU AU2003209669A patent/AU2003209669A1/en not_active Abandoned
- 2003-02-25 WO PCT/IN2003/000037 patent/WO2004076443A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004076443A1 (en) | 2004-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003904256A0 (en) | Qubit readout | |
| AU2003303648A1 (en) | Novel 5-hydroxyindole-3-carboxylate derivatives | |
| AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
| AU2003209669A1 (en) | Amorphous form of losartan potassium | |
| AU2003223106A1 (en) | A novel amorphous form of valsartan | |
| AU2003278422A1 (en) | Amorphous form of losartan potassium | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| GB0314149D0 (en) | Novel amorphous forms | |
| AU2003217509A1 (en) | Germanium bio wallpaper | |
| AU2003264861A1 (en) | Novel crystalline forms of celecoxib | |
| AU2003238678A1 (en) | Novel crystalline forms of sumatriptan succinate | |
| AU2005100106A4 (en) | T&L ezyfume | |
| AU2003242984A1 (en) | A novel crystalline form of irbesartan | |
| AU2004900742A0 (en) | A condom of sheath variation | |
| AU2003248104A1 (en) | Crystalline 6-n-pyridylmethylaminoindolocarbazoles | |
| AU2004100592A4 (en) | Ear hygiene tool | |
| AU2004900525A0 (en) | T & L Ezyfume | |
| AU2004900166A0 (en) | Archimedian Desalinator | |
| AU2003901020A0 (en) | Improvement to catalysators | |
| AU2003905280A0 (en) | Improvements relating to electrodewatering | |
| AU2003269470A1 (en) | A process for the synthesis of losartan potassium | |
| HK1093968A (en) | Substituted furochromene compounds of antiinflammatory action | |
| HK1098756A (en) | Crystalline forms of 9-(s)-erythromycylamine | |
| HK1094801A (en) | Synthesis of pyrrole-2-carbonitriles | |
| HK1069172A (en) | Polymorphs of valsartan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |